Abstract
Background: Disseminated intravascular coagulation (DIC) is a known complication of malignancy. Drug-induced DIC is also reported. Sunitinib is a tyrosine kinase inhibitor approved as an oral targeted therapy in the treatment of different cancers. Here we present a case study of disseminated intravascular coagulation following the administration of Sunitinib after COVID-19 infection in a patient diagnosed with metastatic neuroendocrine tumor of the lung.
Case Report: A 35-year-old male patient with a known metastatic lung neuroendocrine tumor (NET) who was treated with Sunitinib for many years with partial response and tolerating the treatment well-developed recurrent DIC on Sunitinib after COVID-19 infection.
Discussion: COVID-19 infection is reported to be associated with endothelial injury and inflammation. Vascular endothelial growth factor (VEGF) receptors have a role in the protection and modulation of endothelium. Sunitinib is a multikinase inhibitor with anti- VEGF effect. It is possible that endothelial injury after COVID-19 may have triggered recurrent DIC in this patient who had previously tolerated the same drug without problems.
Conclusion:
DIC may be underreported especially with antineoplastics having anti-VEGF effects. Potential risk, interaction, and association with COVID-19 infection in the Era of the pandemic are unclear but warrants further research, and drug-induced DIC should be considered in the differential diagnosis of such cases.
Keywords: DIC, COVID-19, Sunitinib, Drug, Neuroendocrine, Carcinoma.
New Emirates Medical Journal
Title:Sunitinib Induced Disseminated Intravascular Coagulation after COVID-19 Infection in a Patient with Neuroendocrine Tumor: A Case Report
Volume: 5
Author(s): Mona Tareen, Julieta O Zuluaga, Maroun El khoury, Sameh Salem and Faraz Khan*
Affiliation:
- Department of Hematology/Oncology, American Hospital, Dubai, United Arab Emirates
Keywords: DIC, COVID-19, Sunitinib, Drug, Neuroendocrine, Carcinoma.
Abstract:
Background: Disseminated intravascular coagulation (DIC) is a known complication of malignancy. Drug-induced DIC is also reported. Sunitinib is a tyrosine kinase inhibitor approved as an oral targeted therapy in the treatment of different cancers. Here we present a case study of disseminated intravascular coagulation following the administration of Sunitinib after COVID-19 infection in a patient diagnosed with metastatic neuroendocrine tumor of the lung.
Case Report: A 35-year-old male patient with a known metastatic lung neuroendocrine tumor (NET) who was treated with Sunitinib for many years with partial response and tolerating the treatment well-developed recurrent DIC on Sunitinib after COVID-19 infection.
Discussion: COVID-19 infection is reported to be associated with endothelial injury and inflammation. Vascular endothelial growth factor (VEGF) receptors have a role in the protection and modulation of endothelium. Sunitinib is a multikinase inhibitor with anti- VEGF effect. It is possible that endothelial injury after COVID-19 may have triggered recurrent DIC in this patient who had previously tolerated the same drug without problems.
Conclusion:
DIC may be underreported especially with antineoplastics having anti-VEGF effects. Potential risk, interaction, and association with COVID-19 infection in the Era of the pandemic are unclear but warrants further research, and drug-induced DIC should be considered in the differential diagnosis of such cases.
Export Options
About this article
Cite this article as:
Tareen Mona, Zuluaga O Julieta, El khoury Maroun, Salem Sameh and Khan Faraz*, Sunitinib Induced Disseminated Intravascular Coagulation after COVID-19 Infection in a Patient with Neuroendocrine Tumor: A Case Report, New Emirates Medical Journal 2024; 5 : e140723218725 . https://dx.doi.org/10.2174/0250688204666230714110831
DOI https://dx.doi.org/10.2174/0250688204666230714110831 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design, <i>In Silico</i> Molecular Docking, and ADMET Prediction of Amide
Derivatives of Chalcone Nucleus as EGFR Inhibitors for the Treatment of
Cancer
Current Drug Discovery Technologies Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews Editorial [Hot Topic: In Silico Lead Identification and Optimization for Drug Discovery (Executive Guest Editor: Shuxing Zhang)]
Current Pharmaceutical Design Recent Studies of QSAR on Inhibitors of Estrogen Receptor and Human Eosinophil Phosphodiesterase
Current Computer-Aided Drug Design Quinazolinone: Pharmacophore with Endless Pharmacological Actions
Current Indian Science Proteases as Anti-Cancer Targets - Molecular and Biological Basis for Development of Inhibitor-Like Drugs Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Biological Activity of Substituted-4,5,6,7-tetrahydrothieno Pyridines: A Review
Mini-Reviews in Medicinal Chemistry Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review
Central Nervous System Agents in Medicinal Chemistry The Present Utility and Future Potential for Medicinal Chemistry of QSAR / QSPR with Whole Molecule Descriptors
Current Topics in Medicinal Chemistry Graphical Abstracts
Medicinal Chemistry Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry Synthesis, Screening and in silico Simulations of Anti-Parasitic Propamidine/Benzimidazole Derivatives
Medicinal Chemistry Design, Synthesis and Evaluation of Novel 3/4-((Substituted benzamidophenoxy) methyl)-N-hydroxybenzamides/propenamides as Histone Deacetylase Inhibitors and Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews Sigma Receptors and Cocaine Abuse
Current Topics in Medicinal Chemistry Coronavirus Disease COVID-19: A New Threat to Public Health
Current Topics in Medicinal Chemistry Definition of Markov-Harary Invariants and Review of Classic Topological Indices and Databases in Biology, Parasitology, Technology,and Social-Legal Networks
Current Bioinformatics Frequency of Ipsilateral Axillary Lymphadenopathy After the Inactivated COVID-19 Vaccine
Current Medical Imaging Synthesis of Glutamate-Zinc-Aluminium-Layered Double Hydroxide Nanobiocomposites and Cell Viability Study
Current Nanoscience Transient Fever: The Sole Treatment-Related Adverse Event Associated with Mesenchymal Stromal Cells and Solid Clues from the Real World
Current Stem Cell Research & Therapy